Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Echocardiography, Transesophageal | 57 | 2021 | 1085 | 5.760 |
Why?
|
Mitral Valve | 17 | 2020 | 1464 | 2.990 |
Why?
|
Echocardiography, Three-Dimensional | 15 | 2020 | 607 | 2.920 |
Why?
|
Mitral Valve Insufficiency | 16 | 2021 | 1400 | 2.440 |
Why?
|
Coronary Artery Bypass | 48 | 2021 | 2188 | 2.160 |
Why?
|
Cardiac Surgical Procedures | 39 | 2023 | 3621 | 2.030 |
Why?
|
Mitral Valve Stenosis | 7 | 2018 | 341 | 1.760 |
Why?
|
Monitoring, Intraoperative | 19 | 2019 | 941 | 1.600 |
Why?
|
Echocardiography, Doppler, Color | 6 | 2019 | 352 | 1.250 |
Why?
|
Ventricular Outflow Obstruction | 4 | 2016 | 261 | 0.980 |
Why?
|
Echocardiography | 17 | 2021 | 4987 | 0.960 |
Why?
|
Perioperative Care | 12 | 2016 | 1037 | 0.850 |
Why?
|
Anesthesiology | 8 | 2024 | 1122 | 0.820 |
Why?
|
Heart Valve Prosthesis Implantation | 9 | 2021 | 1553 | 0.800 |
Why?
|
Myocardial Ischemia | 9 | 2021 | 2110 | 0.700 |
Why?
|
Cardiopulmonary Bypass | 18 | 2019 | 1092 | 0.700 |
Why?
|
Complement C5 | 7 | 2010 | 103 | 0.690 |
Why?
|
Echocardiography, Doppler | 7 | 2014 | 893 | 0.630 |
Why?
|
Intra-Aortic Balloon Pumping | 5 | 2015 | 223 | 0.630 |
Why?
|
Cardiology | 9 | 2023 | 1656 | 0.620 |
Why?
|
Intraoperative Complications | 13 | 2010 | 1161 | 0.580 |
Why?
|
Intraoperative Care | 9 | 2010 | 767 | 0.540 |
Why?
|
Complement Activation | 5 | 2012 | 445 | 0.490 |
Why?
|
Pericardium | 6 | 2017 | 664 | 0.460 |
Why?
|
Anesthesia | 3 | 2023 | 1591 | 0.460 |
Why?
|
Hemodynamics | 7 | 2019 | 4160 | 0.450 |
Why?
|
Diastole | 2 | 2015 | 781 | 0.430 |
Why?
|
Mitral Valve Annuloplasty | 1 | 2014 | 144 | 0.430 |
Why?
|
Postoperative Complications | 35 | 2017 | 15609 | 0.420 |
Why?
|
Heart Diseases | 6 | 2017 | 2778 | 0.410 |
Why?
|
Myocardial Reperfusion Injury | 4 | 2006 | 481 | 0.400 |
Why?
|
Heart Valves | 5 | 2017 | 284 | 0.380 |
Why?
|
Tricuspid Valve Insufficiency | 4 | 2023 | 352 | 0.370 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2010 | 535 | 0.370 |
Why?
|
Heart Valve Diseases | 7 | 2017 | 1028 | 0.360 |
Why?
|
Heart Aneurysm | 1 | 2010 | 114 | 0.350 |
Why?
|
Suture Techniques | 1 | 2014 | 768 | 0.340 |
Why?
|
Ultrasonography, Interventional | 6 | 2009 | 1496 | 0.320 |
Why?
|
Predictive Value of Tests | 21 | 2019 | 15250 | 0.320 |
Why?
|
Ventricular Function, Left | 6 | 2019 | 3873 | 0.320 |
Why?
|
Embolectomy | 6 | 2006 | 129 | 0.310 |
Why?
|
Heart Ventricles | 8 | 2017 | 3796 | 0.300 |
Why?
|
Pulmonary Embolism | 12 | 2013 | 2568 | 0.300 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2017 | 3356 | 0.290 |
Why?
|
Humans | 161 | 2024 | 760740 | 0.290 |
Why?
|
Single-Chain Antibodies | 10 | 2010 | 111 | 0.280 |
Why?
|
Myocardial Infarction | 16 | 2010 | 11458 | 0.280 |
Why?
|
Creatine Kinase, MB Form | 6 | 2010 | 202 | 0.270 |
Why?
|
Arterio-Arterial Fistula | 1 | 2006 | 20 | 0.270 |
Why?
|
Myxoma | 1 | 2006 | 114 | 0.260 |
Why?
|
Sinus of Valsalva | 1 | 2006 | 60 | 0.260 |
Why?
|
Vena Cava, Superior | 1 | 2006 | 194 | 0.250 |
Why?
|
Societies, Medical | 10 | 2023 | 3901 | 0.250 |
Why?
|
Atrial Fibrillation | 9 | 2019 | 5031 | 0.250 |
Why?
|
Sternum | 1 | 2006 | 175 | 0.250 |
Why?
|
Antibodies, Monoclonal | 10 | 2010 | 9171 | 0.250 |
Why?
|
Renal Replacement Therapy | 1 | 2007 | 281 | 0.240 |
Why?
|
Atrial Appendage | 1 | 2009 | 278 | 0.240 |
Why?
|
Natriuretic Peptide, Brain | 5 | 2013 | 1723 | 0.240 |
Why?
|
Aorta | 5 | 2017 | 2041 | 0.240 |
Why?
|
Pulmonary Artery | 5 | 2019 | 1927 | 0.240 |
Why?
|
Genetic Variation | 6 | 2014 | 6561 | 0.240 |
Why?
|
Ventricular Dysfunction | 3 | 2011 | 144 | 0.240 |
Why?
|
Aortic Aneurysm | 2 | 2006 | 648 | 0.230 |
Why?
|
Middle Aged | 71 | 2022 | 220603 | 0.230 |
Why?
|
Models, Cardiovascular | 4 | 2015 | 981 | 0.230 |
Why?
|
Heart Atria | 5 | 2017 | 1333 | 0.230 |
Why?
|
Ventricular Dysfunction, Left | 7 | 2019 | 2118 | 0.230 |
Why?
|
Male | 87 | 2022 | 360402 | 0.230 |
Why?
|
Aged | 68 | 2022 | 169092 | 0.230 |
Why?
|
Graft Occlusion, Vascular | 1 | 2006 | 537 | 0.210 |
Why?
|
Heart Neoplasms | 1 | 2006 | 362 | 0.210 |
Why?
|
Heart Transplantation | 5 | 2004 | 3233 | 0.210 |
Why?
|
Cardiac Output, Low | 1 | 2003 | 191 | 0.210 |
Why?
|
American Heart Association | 4 | 2023 | 1039 | 0.200 |
Why?
|
Polymorphism, Single Nucleotide | 11 | 2017 | 15908 | 0.200 |
Why?
|
Female | 82 | 2022 | 392203 | 0.200 |
Why?
|
Aged, 80 and over | 29 | 2017 | 58919 | 0.190 |
Why?
|
Catheterization, Central Venous | 1 | 2006 | 526 | 0.190 |
Why?
|
Aortic Valve | 8 | 2017 | 1955 | 0.190 |
Why?
|
Anaphylatoxins | 1 | 2001 | 21 | 0.190 |
Why?
|
Retrospective Studies | 24 | 2023 | 80583 | 0.190 |
Why?
|
Surgery, Computer-Assisted | 1 | 2009 | 1002 | 0.180 |
Why?
|
Reproducibility of Results | 10 | 2016 | 20077 | 0.180 |
Why?
|
Coronary Artery Disease | 6 | 2017 | 6403 | 0.180 |
Why?
|
Coronary Disease | 5 | 2006 | 5911 | 0.180 |
Why?
|
Coronary Vessels | 6 | 2023 | 3095 | 0.170 |
Why?
|
Treatment Outcome | 28 | 2023 | 64572 | 0.170 |
Why?
|
Complement Membrane Attack Complex | 1 | 1999 | 105 | 0.170 |
Why?
|
Polypropylenes | 1 | 1999 | 62 | 0.170 |
Why?
|
Antithrombin III | 2 | 2010 | 128 | 0.170 |
Why?
|
Troponin I | 5 | 2010 | 650 | 0.170 |
Why?
|
Heart | 5 | 2023 | 4403 | 0.160 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2019 | 628 | 0.160 |
Why?
|
Reoperation | 3 | 2018 | 4300 | 0.150 |
Why?
|
Membranes, Artificial | 1 | 1999 | 366 | 0.150 |
Why?
|
Heart Valve Prosthesis | 4 | 2021 | 1462 | 0.150 |
Why?
|
Heart Septal Defects, Ventricular | 2 | 2003 | 477 | 0.150 |
Why?
|
Ventricular Function, Right | 3 | 2019 | 617 | 0.140 |
Why?
|
Stroke Volume | 2 | 2012 | 5486 | 0.140 |
Why?
|
Perioperative Period | 3 | 2013 | 250 | 0.140 |
Why?
|
Heart Failure | 7 | 2019 | 11670 | 0.140 |
Why?
|
Heart Arrest, Induced | 2 | 2015 | 358 | 0.140 |
Why?
|
Aortic Diseases | 2 | 2017 | 735 | 0.140 |
Why?
|
Nitroglycerin | 1 | 1998 | 329 | 0.140 |
Why?
|
Thrombosis | 2 | 2009 | 2942 | 0.140 |
Why?
|
Acute Kidney Injury | 4 | 2016 | 1923 | 0.140 |
Why?
|
Cardiovascular Surgical Procedures | 3 | 2007 | 188 | 0.140 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2006 | 1310 | 0.140 |
Why?
|
Creatine Kinase | 3 | 2005 | 685 | 0.140 |
Why?
|
Anesthetics | 3 | 2014 | 523 | 0.130 |
Why?
|
Heart-Assist Devices | 5 | 2019 | 1288 | 0.130 |
Why?
|
Materials Testing | 1 | 1999 | 863 | 0.130 |
Why?
|
Nitric Oxide | 3 | 1999 | 2135 | 0.130 |
Why?
|
Total Quality Management | 2 | 2006 | 262 | 0.120 |
Why?
|
Lectins | 1 | 2017 | 489 | 0.120 |
Why?
|
Capillaries | 1 | 1998 | 756 | 0.120 |
Why?
|
Haplotypes | 2 | 2014 | 2713 | 0.120 |
Why?
|
Ventricular Remodeling | 1 | 2002 | 1265 | 0.120 |
Why?
|
Forecasting | 3 | 2016 | 2924 | 0.120 |
Why?
|
Thoracic Surgery | 2 | 2013 | 722 | 0.120 |
Why?
|
Prosthesis Implantation | 1 | 2019 | 591 | 0.120 |
Why?
|
Prospective Studies | 22 | 2017 | 54364 | 0.110 |
Why?
|
Alleles | 3 | 2016 | 6861 | 0.110 |
Why?
|
Isoenzymes | 3 | 2005 | 1687 | 0.110 |
Why?
|
Vasodilator Agents | 1 | 1998 | 973 | 0.110 |
Why?
|
Pressure | 3 | 2014 | 1150 | 0.110 |
Why?
|
Heme Oxygenase-1 | 1 | 2016 | 366 | 0.110 |
Why?
|
Severity of Illness Index | 8 | 2023 | 15829 | 0.110 |
Why?
|
Aortic Valve Stenosis | 4 | 2014 | 2003 | 0.110 |
Why?
|
Catheterization | 1 | 1998 | 1428 | 0.110 |
Why?
|
Preoperative Period | 3 | 2010 | 550 | 0.110 |
Why?
|
Cardiovascular Diseases | 5 | 2015 | 15498 | 0.110 |
Why?
|
Practice Guidelines as Topic | 4 | 2017 | 7390 | 0.110 |
Why?
|
Risk Assessment | 11 | 2017 | 23974 | 0.100 |
Why?
|
Proportional Hazards Models | 10 | 2023 | 12448 | 0.100 |
Why?
|
Aorta, Thoracic | 2 | 2012 | 1096 | 0.100 |
Why?
|
Treatment Failure | 1 | 2018 | 2635 | 0.100 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2014 | 195 | 0.100 |
Why?
|
Heparin | 2 | 2010 | 1632 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 737 | 0.100 |
Why?
|
Postoperative Period | 6 | 2017 | 1812 | 0.100 |
Why?
|
Bioprosthesis | 1 | 2016 | 591 | 0.100 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1737 | 0.100 |
Why?
|
Blood Pressure | 3 | 2013 | 8473 | 0.100 |
Why?
|
Risk Factors | 20 | 2019 | 74128 | 0.100 |
Why?
|
Serine Endopeptidases | 2 | 2014 | 1022 | 0.100 |
Why?
|
Electrodes | 1 | 2014 | 610 | 0.100 |
Why?
|
Receptors, Thrombin | 1 | 2012 | 130 | 0.100 |
Why?
|
Data Display | 1 | 2012 | 175 | 0.090 |
Why?
|
Diagnosis, Differential | 4 | 2019 | 12966 | 0.090 |
Why?
|
Diffusion of Innovation | 1 | 2016 | 729 | 0.090 |
Why?
|
Time Factors | 15 | 2022 | 39908 | 0.090 |
Why?
|
Profilins | 1 | 2010 | 65 | 0.090 |
Why?
|
Sequence Analysis, RNA | 2 | 2017 | 2013 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2017 | 11874 | 0.090 |
Why?
|
Adult | 31 | 2022 | 220995 | 0.090 |
Why?
|
Indicator Dilution Techniques | 1 | 2010 | 43 | 0.090 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2015 | 512 | 0.090 |
Why?
|
Analgesics, Opioid | 2 | 2022 | 3805 | 0.090 |
Why?
|
Cardiovascular Agents | 2 | 2016 | 840 | 0.090 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2017 | 1048 | 0.090 |
Why?
|
Heart Injuries | 1 | 2012 | 203 | 0.090 |
Why?
|
Genotype | 6 | 2016 | 12977 | 0.080 |
Why?
|
History, 21st Century | 1 | 2016 | 1566 | 0.080 |
Why?
|
Heart-Lung Machine | 2 | 2010 | 44 | 0.080 |
Why?
|
Lipocalins | 1 | 2010 | 161 | 0.080 |
Why?
|
United States | 17 | 2023 | 72292 | 0.080 |
Why?
|
Shock | 2 | 2006 | 314 | 0.080 |
Why?
|
Intraoperative Period | 3 | 2013 | 510 | 0.080 |
Why?
|
Device Removal | 1 | 2014 | 629 | 0.080 |
Why?
|
Polymorphism, Genetic | 3 | 2016 | 4242 | 0.080 |
Why?
|
Quantitative Trait Loci | 1 | 2017 | 2112 | 0.080 |
Why?
|
Thromboembolism | 2 | 2006 | 991 | 0.080 |
Why?
|
Length of Stay | 7 | 2010 | 6418 | 0.080 |
Why?
|
Clinical Competence | 5 | 2023 | 4790 | 0.080 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2009 | 375 | 0.080 |
Why?
|
Chordae Tendineae | 1 | 2008 | 39 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 1241 | 0.080 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 1999 | 1462 | 0.080 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2010 | 295 | 0.080 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2011 | 451 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 2 | 2010 | 1810 | 0.070 |
Why?
|
History, 20th Century | 1 | 2016 | 2764 | 0.070 |
Why?
|
Preoperative Care | 4 | 2010 | 2242 | 0.070 |
Why?
|
C-Reactive Protein | 2 | 2010 | 3820 | 0.070 |
Why?
|
Complement C3-C5 Convertases | 1 | 2007 | 30 | 0.070 |
Why?
|
Catheterization, Swan-Ganz | 2 | 2010 | 86 | 0.070 |
Why?
|
Mannose-Binding Protein-Associated Serine Proteases | 1 | 2007 | 20 | 0.070 |
Why?
|
Complement Pathway, Mannose-Binding Lectin | 1 | 2007 | 28 | 0.070 |
Why?
|
Cardiac Output | 1 | 2010 | 831 | 0.070 |
Why?
|
Heart Septum | 1 | 2008 | 299 | 0.070 |
Why?
|
Troponin | 1 | 2010 | 502 | 0.070 |
Why?
|
Double-Blind Method | 9 | 2010 | 12333 | 0.070 |
Why?
|
Mannose-Binding Lectins | 1 | 2007 | 96 | 0.070 |
Why?
|
Ischemia | 1 | 2015 | 1885 | 0.070 |
Why?
|
Mannose-Binding Lectin | 1 | 2007 | 145 | 0.070 |
Why?
|
Infusions, Intravenous | 3 | 2010 | 2214 | 0.070 |
Why?
|
Sufentanil | 1 | 2006 | 42 | 0.070 |
Why?
|
Hypotension | 3 | 2015 | 879 | 0.070 |
Why?
|
Injections, Intravenous | 3 | 2005 | 1376 | 0.070 |
Why?
|
Sutures | 1 | 2008 | 282 | 0.070 |
Why?
|
Complement Inactivating Agents | 1 | 2006 | 53 | 0.060 |
Why?
|
Plaque, Atherosclerotic | 1 | 2017 | 1533 | 0.060 |
Why?
|
Fistula | 1 | 2007 | 212 | 0.060 |
Why?
|
Image Enhancement | 2 | 2007 | 2881 | 0.060 |
Why?
|
Linkage Disequilibrium | 1 | 2009 | 1994 | 0.060 |
Why?
|
Peripheral Vascular Diseases | 1 | 2007 | 488 | 0.060 |
Why?
|
Aortic Valve Insufficiency | 1 | 2009 | 576 | 0.060 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2010 | 1492 | 0.060 |
Why?
|
Europe | 4 | 2012 | 3415 | 0.060 |
Why?
|
Odds Ratio | 3 | 2015 | 9644 | 0.060 |
Why?
|
Immunoassay | 1 | 2007 | 744 | 0.050 |
Why?
|
Cardiomyopathies | 2 | 2010 | 1948 | 0.050 |
Why?
|
Atherosclerosis | 2 | 2010 | 3400 | 0.050 |
Why?
|
Logistic Models | 4 | 2015 | 13248 | 0.050 |
Why?
|
Postoperative Hemorrhage | 2 | 2005 | 414 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6473 | 0.050 |
Why?
|
Decision Making | 2 | 2014 | 3919 | 0.050 |
Why?
|
Follow-Up Studies | 11 | 2017 | 39062 | 0.050 |
Why?
|
Survival Analysis | 7 | 2013 | 10072 | 0.050 |
Why?
|
Primary Prevention | 1 | 2010 | 1185 | 0.050 |
Why?
|
Embolism, Air | 2 | 2013 | 109 | 0.050 |
Why?
|
Ischemic Attack, Transient | 1 | 2008 | 874 | 0.050 |
Why?
|
Cytokines | 1 | 2017 | 7373 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1780 | 0.050 |
Why?
|
Vena Cava Filters | 1 | 2005 | 261 | 0.050 |
Why?
|
Myocardium | 1 | 2015 | 4725 | 0.050 |
Why?
|
Acidosis | 1 | 2004 | 268 | 0.050 |
Why?
|
Sensitivity and Specificity | 5 | 2008 | 14649 | 0.050 |
Why?
|
Hospital Mortality | 3 | 2012 | 5292 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2011 | 2419 | 0.050 |
Why?
|
Heart Arrest | 2 | 2015 | 1513 | 0.050 |
Why?
|
Sternotomy | 1 | 2022 | 128 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2006 | 3245 | 0.050 |
Why?
|
Physical Examination | 1 | 2007 | 1254 | 0.050 |
Why?
|
Blood Platelets | 1 | 2012 | 2478 | 0.050 |
Why?
|
Hospital Costs | 1 | 2007 | 947 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2012 | 2222 | 0.050 |
Why?
|
Coronary Circulation | 3 | 2010 | 1569 | 0.050 |
Why?
|
Vascular Resistance | 1 | 2004 | 930 | 0.050 |
Why?
|
Pharmacogenetics | 1 | 2005 | 675 | 0.050 |
Why?
|
Health Resources | 1 | 2007 | 934 | 0.050 |
Why?
|
Texas | 2 | 2013 | 403 | 0.050 |
Why?
|
Cardiotonic Agents | 3 | 2010 | 539 | 0.040 |
Why?
|
Electrocardiography | 3 | 2014 | 6346 | 0.040 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 2018 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 3 | 2017 | 17878 | 0.040 |
Why?
|
Shock, Cardiogenic | 1 | 2005 | 709 | 0.040 |
Why?
|
Survival Rate | 5 | 2014 | 12719 | 0.040 |
Why?
|
Longitudinal Studies | 6 | 2014 | 14599 | 0.040 |
Why?
|
Surgical Procedures, Operative | 1 | 2011 | 1924 | 0.040 |
Why?
|
Cattle | 2 | 2009 | 3841 | 0.040 |
Why?
|
Thrombectomy | 1 | 2004 | 702 | 0.040 |
Why?
|
Cohort Studies | 9 | 2014 | 41464 | 0.040 |
Why?
|
Platelet Adhesiveness | 1 | 1999 | 154 | 0.040 |
Why?
|
Respiration | 1 | 2006 | 1656 | 0.040 |
Why?
|
Embolism | 1 | 2002 | 399 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3802 | 0.040 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 1901 | 0.040 |
Why?
|
Aortography | 1 | 2001 | 421 | 0.040 |
Why?
|
Central Venous Pressure | 1 | 2019 | 79 | 0.040 |
Why?
|
Blood Transfusion, Autologous | 1 | 1999 | 130 | 0.040 |
Why?
|
Anesthesia, General | 1 | 2006 | 1173 | 0.040 |
Why?
|
Blood Gas Analysis | 1 | 1999 | 379 | 0.040 |
Why?
|
Area Under Curve | 2 | 2015 | 1635 | 0.040 |
Why?
|
Endocarditis | 1 | 2002 | 348 | 0.040 |
Why?
|
Heart Defects, Congenital | 3 | 2013 | 4671 | 0.040 |
Why?
|
Analgesics | 1 | 2005 | 1067 | 0.040 |
Why?
|
Consensus | 2 | 2021 | 3117 | 0.040 |
Why?
|
Neuroprotective Agents | 1 | 2004 | 957 | 0.040 |
Why?
|
Pulsatile Flow | 1 | 2019 | 320 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 4512 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4583 | 0.040 |
Why?
|
Psychological Tests | 1 | 1999 | 639 | 0.040 |
Why?
|
Piperidines | 1 | 2006 | 1655 | 0.040 |
Why?
|
Critical Care | 1 | 2010 | 2691 | 0.040 |
Why?
|
Equipment Failure | 2 | 2014 | 577 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2006 | 1589 | 0.040 |
Why?
|
Hemostasis | 1 | 2019 | 469 | 0.030 |
Why?
|
Peer Review, Health Care | 2 | 2006 | 73 | 0.030 |
Why?
|
Blood Circulation | 1 | 1997 | 248 | 0.030 |
Why?
|
Pain Measurement | 2 | 2022 | 3546 | 0.030 |
Why?
|
Cyclic GMP | 1 | 2017 | 395 | 0.030 |
Why?
|
GPI-Linked Proteins | 1 | 2017 | 469 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 1999 | 636 | 0.030 |
Why?
|
Swine | 2 | 2009 | 5908 | 0.030 |
Why?
|
Ventricular Function | 1 | 1997 | 406 | 0.030 |
Why?
|
Prognosis | 4 | 2023 | 29601 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 1999 | 1148 | 0.030 |
Why?
|
Adipokines | 1 | 2017 | 308 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2011 | 12661 | 0.030 |
Why?
|
ROC Curve | 2 | 2015 | 3575 | 0.030 |
Why?
|
China | 1 | 2021 | 2374 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2015 | 223 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3634 | 0.030 |
Why?
|
Fluoroscopy | 1 | 1998 | 945 | 0.030 |
Why?
|
Blood Proteins | 1 | 1999 | 1172 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2017 | 6223 | 0.030 |
Why?
|
Protein Binding | 2 | 2012 | 9345 | 0.030 |
Why?
|
Membrane Potentials | 1 | 2017 | 1089 | 0.030 |
Why?
|
Genomics | 2 | 2011 | 5822 | 0.030 |
Why?
|
Chromogranins | 1 | 2014 | 160 | 0.030 |
Why?
|
Hospitalization | 1 | 2013 | 10708 | 0.030 |
Why?
|
Regression Analysis | 3 | 2010 | 6339 | 0.030 |
Why?
|
Stroke | 3 | 2017 | 9715 | 0.030 |
Why?
|
Cell Adhesion | 1 | 1999 | 3088 | 0.030 |
Why?
|
Quality Assurance, Health Care | 2 | 2013 | 2164 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2010 | 2925 | 0.030 |
Why?
|
Dual Specificity Phosphatase 2 | 1 | 2012 | 5 | 0.030 |
Why?
|
Animals | 8 | 2016 | 168202 | 0.030 |
Why?
|
Counterpulsation | 1 | 2012 | 16 | 0.030 |
Why?
|
Myocardial Revascularization | 1 | 1996 | 790 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2010 | 3410 | 0.020 |
Why?
|
Angina Pectoris | 1 | 1996 | 959 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2017 | 1152 | 0.020 |
Why?
|
Leukocytes | 1 | 1999 | 2024 | 0.020 |
Why?
|
Databases, Factual | 2 | 2017 | 7963 | 0.020 |
Why?
|
Education, Medical, Continuing | 2 | 2006 | 825 | 0.020 |
Why?
|
Cold Temperature | 1 | 2015 | 785 | 0.020 |
Why?
|
Pericardial Effusion | 1 | 2013 | 247 | 0.020 |
Why?
|
Rats, Inbred WKY | 1 | 2010 | 150 | 0.020 |
Why?
|
Systole | 1 | 2013 | 935 | 0.020 |
Why?
|
Accidental Falls | 1 | 2019 | 1067 | 0.020 |
Why?
|
Acute Disease | 2 | 2015 | 7236 | 0.020 |
Why?
|
Esophageal Perforation | 1 | 2010 | 64 | 0.020 |
Why?
|
Ventricular Pressure | 1 | 2011 | 210 | 0.020 |
Why?
|
Thoracic Injuries | 1 | 2013 | 288 | 0.020 |
Why?
|
Whole Blood Coagulation Time | 1 | 2010 | 30 | 0.020 |
Why?
|
Coronary Stenosis | 2 | 2008 | 794 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2010 | 181 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9417 | 0.020 |
Why?
|
Myoglobin | 1 | 2010 | 159 | 0.020 |
Why?
|
Equipment Design | 2 | 2008 | 3501 | 0.020 |
Why?
|
Lithium Chloride | 1 | 2010 | 82 | 0.020 |
Why?
|
Hypertension | 1 | 2010 | 8532 | 0.020 |
Why?
|
Growth Hormone | 1 | 1991 | 569 | 0.020 |
Why?
|
Receptors, Atrial Natriuretic Factor | 1 | 2009 | 43 | 0.020 |
Why?
|
Clinical Enzyme Tests | 1 | 2009 | 113 | 0.020 |
Why?
|
P-Selectin | 1 | 2012 | 599 | 0.020 |
Why?
|
Acute-Phase Reaction | 1 | 2009 | 91 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2010 | 460 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2006 | 10203 | 0.020 |
Why?
|
Laser Therapy | 1 | 1996 | 1093 | 0.020 |
Why?
|
Platelet Count | 1 | 2012 | 780 | 0.020 |
Why?
|
Acute-Phase Proteins | 1 | 2010 | 250 | 0.020 |
Why?
|
Boston | 2 | 2013 | 9313 | 0.020 |
Why?
|
Emergencies | 2 | 2006 | 1217 | 0.020 |
Why?
|
Hemoglobinuria | 1 | 2008 | 12 | 0.020 |
Why?
|
Propensity Score | 1 | 2016 | 1912 | 0.020 |
Why?
|
Biomedical Research | 1 | 2024 | 3426 | 0.020 |
Why?
|
Assisted Circulation | 1 | 2008 | 100 | 0.020 |
Why?
|
Registries | 2 | 2015 | 8209 | 0.020 |
Why?
|
Platelet Activation | 1 | 2012 | 646 | 0.020 |
Why?
|
Young Adult | 5 | 2015 | 59191 | 0.020 |
Why?
|
Linear Models | 2 | 2009 | 5866 | 0.020 |
Why?
|
Atrial Natriuretic Factor | 1 | 2009 | 350 | 0.020 |
Why?
|
Oxygen | 1 | 1999 | 4226 | 0.020 |
Why?
|
von Willebrand Factor | 1 | 2012 | 676 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3601 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2734 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2009 | 5239 | 0.020 |
Why?
|
Signal Transduction | 4 | 2017 | 23415 | 0.020 |
Why?
|
Hemorrhage | 1 | 2019 | 3418 | 0.020 |
Why?
|
Papillary Muscles | 1 | 2008 | 192 | 0.020 |
Why?
|
Laboratories | 1 | 2011 | 458 | 0.020 |
Why?
|
Polytetrafluoroethylene | 1 | 2008 | 245 | 0.020 |
Why?
|
Pulmonary Circulation | 1 | 2010 | 737 | 0.020 |
Why?
|
Cause of Death | 1 | 2017 | 3683 | 0.020 |
Why?
|
Computer Systems | 1 | 2008 | 469 | 0.020 |
Why?
|
Homozygote | 1 | 2012 | 1776 | 0.020 |
Why?
|
North America | 1 | 2010 | 1273 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2015 | 992 | 0.020 |
Why?
|
Transducers | 1 | 2008 | 244 | 0.020 |
Why?
|
Constriction | 1 | 2006 | 168 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1745 | 0.020 |
Why?
|
Life Tables | 1 | 2006 | 364 | 0.020 |
Why?
|
Oligopeptides | 1 | 2012 | 1185 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 2817 | 0.020 |
Why?
|
Hemolysis | 1 | 2008 | 415 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2008 | 843 | 0.020 |
Why?
|
Premedication | 1 | 2006 | 245 | 0.020 |
Why?
|
Cognition Disorders | 1 | 1999 | 3979 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2017 | 3310 | 0.020 |
Why?
|
Genes | 1 | 2009 | 1823 | 0.020 |
Why?
|
Pulmonary Atelectasis | 1 | 2006 | 143 | 0.020 |
Why?
|
Safety Management | 1 | 2010 | 760 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6763 | 0.010 |
Why?
|
Sick Sinus Syndrome | 1 | 2004 | 44 | 0.010 |
Why?
|
Age Factors | 2 | 2016 | 18381 | 0.010 |
Why?
|
Operating Rooms | 1 | 2011 | 790 | 0.010 |
Why?
|
Blood | 1 | 2007 | 596 | 0.010 |
Why?
|
Creatinine | 1 | 2010 | 1895 | 0.010 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2004 | 34 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1335 | 0.010 |
Why?
|
Neuromuscular Blocking Agents | 1 | 2005 | 129 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1991 | 1932 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 4937 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1884 | 0.010 |
Why?
|
Ligation | 1 | 2004 | 446 | 0.010 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2010 | 1116 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2007 | 12043 | 0.010 |
Why?
|
Temperature | 1 | 2010 | 2224 | 0.010 |
Why?
|
Recurrence | 2 | 2006 | 8426 | 0.010 |
Why?
|
Surgical Wound Infection | 2 | 2004 | 1529 | 0.010 |
Why?
|
Pulmonary Veins | 1 | 2008 | 716 | 0.010 |
Why?
|
Narcotics | 1 | 2005 | 335 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2008 | 1204 | 0.010 |
Why?
|
Phenotype | 2 | 2015 | 16572 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2010 | 1493 | 0.010 |
Why?
|
Observer Variation | 1 | 2009 | 2607 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2475 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2013 | 2067 | 0.010 |
Why?
|
Ebstein Anomaly | 1 | 2003 | 105 | 0.010 |
Why?
|
Critical Illness | 1 | 2015 | 2709 | 0.010 |
Why?
|
Postoperative Care | 1 | 2008 | 1467 | 0.010 |
Why?
|
Hypolipidemic Agents | 1 | 2006 | 609 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10507 | 0.010 |
Why?
|
Infant | 1 | 2003 | 36157 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1700 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8619 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6074 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 2006 | 1683 | 0.010 |
Why?
|
Complement System Proteins | 1 | 2004 | 734 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8652 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12759 | 0.010 |
Why?
|
Propofol | 1 | 2006 | 602 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6807 | 0.010 |
Why?
|
Inflammation | 1 | 1999 | 10759 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3316 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2006 | 1023 | 0.010 |
Why?
|
Incidental Findings | 1 | 2004 | 697 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12420 | 0.010 |
Why?
|
Phosphorylation | 1 | 2010 | 8311 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7569 | 0.010 |
Why?
|
Pacemaker, Artificial | 1 | 2004 | 805 | 0.010 |
Why?
|
Incidence | 2 | 2008 | 21339 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2005 | 1470 | 0.010 |
Why?
|
Genome, Human | 1 | 2011 | 4421 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2003 | 1835 | 0.010 |
Why?
|
Mediastinum | 1 | 1999 | 266 | 0.010 |
Why?
|
Hypnotics and Sedatives | 1 | 2006 | 1178 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 2006 | 1331 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10754 | 0.010 |
Why?
|
Syndrome | 1 | 2004 | 3268 | 0.010 |
Why?
|
Artifacts | 1 | 2006 | 1910 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2010 | 7805 | 0.010 |
Why?
|
Patient Selection | 1 | 2008 | 4237 | 0.010 |
Why?
|
Atrial Function, Left | 1 | 1997 | 183 | 0.010 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 1996 | 174 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2007 | 13442 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 2270 | 0.010 |
Why?
|
Tissue Donors | 1 | 2004 | 2329 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 18937 | 0.010 |
Why?
|
Erythrocyte Transfusion | 1 | 1999 | 568 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 17630 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23716 | 0.010 |
Why?
|
Obesity, Morbid | 1 | 2005 | 1276 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 1997 | 1156 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2012 | 22153 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2007 | 3743 | 0.010 |
Why?
|
Adolescent | 2 | 2015 | 88247 | 0.010 |
Why?
|
Pneumonia | 1 | 2004 | 2143 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 29869 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 8516 | 0.010 |
Why?
|
Ultrasonography | 1 | 2005 | 5965 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1996 | 1972 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 14024 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 1991 | 671 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81368 | 0.010 |
Why?
|
Child | 2 | 2008 | 80089 | 0.000 |
Why?
|
Cognition | 1 | 2004 | 6988 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1991 | 6520 | 0.000 |
Why?
|
Burns | 1 | 1991 | 1875 | 0.000 |
Why?
|
Mutation | 1 | 2004 | 30015 | 0.000 |
Why?
|